ZNF807P: A Drug Target / Disease Biomarker (G100129800)
ZNF807P: A Drug Target / Disease Biomarker
ZNF807P is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZNF807P is a member of the ZNF gene family, which is known for its role in regulating gene expression and cell behavior.
The ZNF807P gene has been shown to play a role in the development and progression of various diseases. For example, studies have shown that ZNF807P is highly expressed in various cancer types, including breast, ovarian, and colorectal cancer. Additionally, ZNF807P has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.
One of the key features of ZNF807P is its role in regulating the activity of other genes. Studies have shown that ZNF807P can interact with a variety of transcription factors, including NF-kappa-B, TGF-β, and Wnt. These interactions can affect the expression of target genes and contribute to the regulation of various cellular processes.
Another important function of ZNF807P is its role in cell signaling. Studies have shown that ZNF807P can interact with the protein TrkA, which is a G protein-coupled receptor that plays a role in cell signaling. These interactions can modulate the activity of TrkA and influence the signaling pathways that are involved in various cellular processes, including cell growth, differentiation, and survival.
In addition to its role in cell signaling, ZNF807P is also involved in the regulation of gene expression. Studies have shown that ZNF807P can interact with the protein YAP/TAZ, which is a complex that is involved in the regulation of cellular processes such as cell adhesion, migration, and invasion. These interactions can affect the activity of YAP/TAZ and influence the translation of ZNF807P into a protein that can be targeted for drug development.
Given the potential role of ZNF807P in the regulation of cellular processes and the regulation of gene expression, it is a promising target for drug development. Studies have shown that ZNF807P can be effectively targeted for drug delivery using various delivery systems, including nanoparticles and liposomes. These studies have demonstrated the ability to load ZNF807P onto these delivery systems and deliver them to cells in a controlled manner.
In addition to its potential as a drug target, ZNF807P has also been shown to be a potential biomarker for various diseases. Studies have shown that ZNF807P can be expressed and purified from various tissues, including cancer cells, and can be used as a protein biomarker for disease diagnosis and monitoring. These studies have demonstrated the ability to quantify the expression of ZNF807P in various tissues and to use it as a marker for disease progression and response to therapy.
Overall, ZNF807P is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role in the regulation of cellular processes and its potential as a drug or biomarker.
Protein Name: Zinc Finger Protein 807, Pseudogene
The "ZNF807P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF807P comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A | ZNG1B | ZNG1C | ZNG1E | ZNG1F | ZNHIT1 | ZNHIT2 | ZNHIT3 | ZNHIT6 | ZNRD2 | ZNRD2-DT | ZNRF1 | ZNRF2 | ZNRF2P1 | ZNRF3 | ZNRF3-AS1 | ZNRF4 | ZP1 | ZP2 | ZP3 | ZP4 | ZPBP | ZPBP2 | ZPLD1 | ZPLD2P | ZPR1 | ZRANB1 | ZRANB2 | ZRANB2-AS1 | ZRANB2-DT | ZRANB3 | ZRS | ZRSR2 | ZRSR2P1 | ZSCAN1 | ZSCAN10 | ZSCAN12 | ZSCAN12P1 | ZSCAN16 | ZSCAN16-AS1 | ZSCAN18 | ZSCAN2 | ZSCAN20 | ZSCAN21 | ZSCAN22
